Targeting ADAM17 in leukocytes increases neutrophil recruitment and reduces bacterial spread during polymicrobial

Hemant K Mishra1, Timothy J Johnson1, Davis M Seelig2

  • 1Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, USA; and.

Insights

Sepsis impairs neutrophil recruitment, but blocking a disintegrin and metalloprotease-17 (ADAM17) in leukocytes improves survival. Reduced bacterial spread and inflammation were observed in ADAM17-deficient mice, highlighting its role in sepsis severity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pathophysiology

Background:

  • Neutrophil recruitment is crucial for fighting infection but is impaired during sepsis.
  • Sepsis involves systemic inflammation and reduced immune cell function.
  • Leukocyte activation during sepsis induces a disintegrin and metalloprotease-17 (ADAM17) activity.

Purpose of the Study:

  • To investigate the role of ADAM17 in leukocyte function during sepsis.
  • To determine if inhibiting ADAM17 in leukocytes improves sepsis outcomes.

Main Methods:

  • Conditional knockout mice lacking ADAM17 in leukocytes were subjected to polymicrobial sepsis.
  • Survival rates, bacterial load, cytokine levels, and neutrophil recruitment were assessed.

Main Results:

  • Conditional knockout mice lacking ADAM17 in leukocytes showed improved survival during sepsis.
  • Bacteremia and pro-inflammatory cytokine levels were significantly reduced in knockout mice.
  • Peritoneal bacterial spread was reduced, with enhanced neutrophil recruitment observed in knockout mice.

Conclusions:

  • ADAM17 activity in leukocytes significantly contributes to sepsis severity.
  • Inhibiting ADAM17 in leukocytes enhances neutrophil recruitment and improves outcomes during sepsis.
  • Targeting ADAM17 may offer a therapeutic strategy for sepsis.

Related Concept Videos